Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Growth Outlook Reveals A CAGR Of 12.6% And A Market Value Of $16.95 Billion By 2030
Implantable neuromodulation and SCS devices market size reached $10.53 billion in 2026 and is expected to grow to $16.96 billion by 2030 at a 12.6% CAGR. Major players: Medtronic plc, Abbott Laboratories.

